1. Hearing Outcomes with Percutaneous and Transcutaneous BAHA® Technology in Conductive and Mixed Hearing Loss.
- Author
-
Tobia A, Yehudai N, Khnifes R, Shpak T, Roth O, Khayr R, and Luntz M
- Subjects
- Bone Conduction, Hearing, Hearing Loss, Conductive therapy, Humans, Quality of Life, Retrospective Studies, Technology, Hearing Aids, Hearing Loss, Mixed Conductive-Sensorineural
- Abstract
Objectives: To evaluate outcomes of BAHA Connect® and BAHA Attract® implantations, and to examine the prognostic utility of a preimplantation Softband®-attached processor trial., Study Design: Retrospective case review., Setting: Tertiary referral center., Patients: Patients who underwent Connect® (19 ears) and Attract® (25 ears) implantation between 2007 and 2017., Intervention: BAHA® implantation., Main Outcome Measures: Unaided air conduction (AC), bone conduction (BC), and speech reception thresholds (SRTs), as well as free field (FF) aided with Softband®-attached processor and with implant-attached processor thresholds., Results: Serviceable implant-attached processor PTA0.5,1,2 kHz (≤35 dB HL) was achieved in 89 and 88% of the Connect® and the Attract® ears, respectively, while at 4 kHz this was achieved in 68 and 32% of the Connect® and the Attract® ears, respectively (p = 0.032). Significantly more Connect® ears showed alignment between FF aided with implant-attached processors thresholds and BC thresholds. The alignment between the Softband®-attached processors thresholds and implant-attached processors thresholds was similar in the two groups. Both groups exhibited similar positive improvement in the quality of life questionnaires., Conclusions: Accessibility to sound with the implant-attached processor is well predicted by the pre-implantation Softband® trial, both in the BAHA Connect® and in the BAHA Attract® ears. Hearing rehabilitation targets at 0.5, 1, and 2 kHz are met by most Connect® and Attract® ears, while at 4 kHz the outcome with Attract® is poorer. This information should be presented to the patient during consultation prior to a decision as to the type of BAHA® device to be implanted., Competing Interests: The authors disclose no conflicts of interest., (Copyright © 2021, Otology & Neurotology, Inc.)
- Published
- 2021
- Full Text
- View/download PDF